Insulins as Drugs or Biologics in the USA: What Difference Does it Make and Why Does it Matter?

被引：0

作者：

Kelly George

Gillian Woollett

机构：

[1] Avalere Health LLC,

[2] FDA Policy,undefined

[3] Avalere Health LLC,undefined

来源：

BioDrugs | 2019年 / 33卷

关键词：

D O I：

暂无

中图分类号：

学科分类号：

摘要：

The status of insulins in the USA is about to change as a regulatory matter. After 23 Mar 2020 they, and other hormone products previously regulated as drugs by the US Food and Drug Administration (FDA), even though biologics in science, will become biologics as a regulatory matter too and will be licensed under the Public Health Service Act. This has a number of ramifications for sponsors, patients, and their physicians.

引用

页码：447 / 451

页数：4

共 50 条

[1] Insulins as Drugs or Biologics in the USA: What Difference Does it Make and Why Does it Matter?
George, Kelly
Woollett, Gillian
BIODRUGS, 2019, 33 (05) : 447 - 451
[2] Threat and Risk: What Is the Difference and Why Does It Matter?
Strachan-Morris, David
INTELLIGENCE AND NATIONAL SECURITY, 2012, 27 (02) : 172 - 186
[3] What difference does difference make?
Watts, Michael
REVIEW OF INTERNATIONAL POLITICAL ECONOMY, 1994, 1 (03) : 563 - 570
[4] WHAT DIFFERENCE DOES IT MAKE
PETERSON, AF
AMERICAN JOURNAL OF PHARMACEUTICAL EDUCATION, 1971, 35 (02) : 267 - &
[5] What difference does it make?
Shively, S
JOURNAL OF VISUAL IMPAIRMENT & BLINDNESS, 1998, 92 (03) : 131 - 131
[6] 'WHAT DIFFERENCE DOES IT MAKE'
SAJE, N
PLOUGHSHARES, 1993, 19 (01) : 156 - 158
[7] What Difference Does It Make?
Marshall, Joretta L.
TEACHING THEOLOGY AND RELIGION, 2007, 10 (03): : 158 - 161
[8] What does make the difference?
Skinner, T. C.
DIABETIC MEDICINE, 2006, 23 (09) : 933 - 934
[9] What difference does it make?
Hareven, TK
SOCIAL SCIENCE HISTORY, 1996, 20 (03) : 317 - 344
[10] What is the minimal clinically important difference, and why does it matter?
Simoes, Maria do Socorro
Patino, Cecilia M.
Ferreira, Juliana Carvalho
JORNAL BRASILEIRO DE PNEUMOLOGIA, 2021, 47 (03)

← 1 2 3 4 5 →